These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32560030)

  • 1. Per- and Polyfluoroalkyl Substances in Early Pregnancy and Risk for Preeclampsia: A Case-Control Study in Southern Sweden.
    Rylander L; Lindh CH; Hansson SR; Broberg K; Källén K
    Toxics; 2020 Jun; 8(2):. PubMed ID: 32560030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy-induced changes in serum concentrations of perfluoroalkyl substances and the influence of kidney function.
    Nielsen C; Andersson Hall U; Lindh C; Ekström U; Xu Y; Li Y; Holmäng A; Jakobsson K
    Environ Health; 2020 Jul; 19(1):80. PubMed ID: 32641055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal trends and predictors of perfluoroalkyl substances serum levels in Swedish pregnant women in the SELMA study.
    Shu H; Lindh CH; Wikström S; Bornehag CG
    PLoS One; 2018; 13(12):e0209255. PubMed ID: 30596681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of plasma concentrations of perfluoroalkyl and polyfluoroalkyl substances in pregnant women from a birth cohort in Shanghai, China.
    Tian Y; Zhou Y; Miao M; Wang Z; Yuan W; Liu X; Wang X; Wang Z; Wen S; Liang H
    Environ Int; 2018 Oct; 119():165-173. PubMed ID: 29958117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of perfluoroalkyl substances with gestational hypertension and preeclampsia in the MIREC study.
    Borghese MM; Walker M; Helewa ME; Fraser WD; Arbuckle TE
    Environ Int; 2020 Aug; 141():105789. PubMed ID: 32408216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variability of perfluoroalkyl substance concentrations in pregnant women by socio-demographic and dietary factors in a Spanish birth cohort.
    Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Martinez D; Ibarluzea J; Santa-Marina L; Schettgen T; Vioque J; Sunyer J; Vrijheid M
    Environ Int; 2016; 92-93():357-65. PubMed ID: 27132161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentrations of perfluoroalkyl substances (PFASs) in human embryonic and fetal organs from first, second, and third trimester pregnancies.
    Mamsen LS; Björvang RD; Mucs D; Vinnars MT; Papadogiannakis N; Lindh CH; Andersen CY; Damdimopoulou P
    Environ Int; 2019 Mar; 124():482-492. PubMed ID: 30684806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal plasma concentrations of Perfluoroalkyl and polyfluoroalkyl substances and neuropsychological development in children at four years of age.
    Niu J; Liang H; Tian Y; Yuan W; Xiao H; Hu H; Sun X; Song X; Wen S; Yang L; Ren Y; Miao M
    Environ Health; 2019 Jun; 18(1):53. PubMed ID: 31196101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Per- and polyfluoroalkyl substances in human serum and urine samples from a residentially exposed community.
    Worley RR; Moore SM; Tierney BC; Ye X; Calafat AM; Campbell S; Woudneh MB; Fisher J
    Environ Int; 2017 Sep; 106():135-143. PubMed ID: 28645013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of per- and polyfluoroalkyl substances (PFAS) in midlife women: Evidence of racial/ethnic and geographic differences in PFAS exposure.
    Park SK; Peng Q; Ding N; Mukherjee B; Harlow SD
    Environ Res; 2019 Aug; 175():186-199. PubMed ID: 31129528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Perfluoroalkyl Substances, Bone Mineral Density, and Osteoporosis in the U.S. Population in NHANES 2009-2010.
    Khalil N; Chen A; Lee M; Czerwinski SA; Ebert JR; DeWitt JC; Kannan K
    Environ Health Perspect; 2016 Jan; 124(1):81-7. PubMed ID: 26058082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Considering environmental exposures to per- and polyfluoroalkyl substances (PFAS) as risk factors for hypertensive disorders of pregnancy.
    Erinc A; Davis MB; Padmanabhan V; Langen E; Goodrich JM
    Environ Res; 2021 Jun; 197():111113. PubMed ID: 33823190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal exposure to perfluoroalkyl substances and birth outcomes in a Spanish birth cohort.
    Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Iñiguez C; Martinez D; Costa O; Santa-Marina L; Pereda-Pereda E; Schettgen T; Sunyer J; Vrijheid M
    Environ Int; 2017 Nov; 108():278-284. PubMed ID: 28917208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal Plasma per- and Polyfluoroalkyl Substance Concentrations in Early Pregnancy and Maternal and Neonatal Thyroid Function in a Prospective Birth Cohort: Project Viva (USA).
    Preston EV; Webster TF; Oken E; Claus Henn B; McClean MD; Rifas-Shiman SL; Pearce EN; Braverman LE; Calafat AM; Ye X; Sagiv SK
    Environ Health Perspect; 2018 Feb; 126(2):027013. PubMed ID: 29488882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants and Temporal Trends of Perfluoroalkyl Substances in Pregnant Women: The Hokkaido Study on Environment and Children's Health.
    Tsai MS; Miyashita C; Araki A; Itoh S; Bamai YA; Goudarzi H; Okada E; Kashino I; Matsuura H; Kishi R
    Int J Environ Res Public Health; 2018 May; 15(5):. PubMed ID: 29758015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal exposure to 11 perfluoroalkyl substances and fetal growth: A large-scale, prospective birth cohort study.
    Kashino I; Sasaki S; Okada E; Matsuura H; Goudarzi H; Miyashita C; Okada E; Ito YM; Araki A; Kishi R
    Environ Int; 2020 Mar; 136():105355. PubMed ID: 32029284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal serum concentrations of per- and polyfluoroalkyl substances and their predictors in years with reduced production and use.
    Berg V; Nøst TH; Huber S; Rylander C; Hansen S; Veyhe AS; Fuskevåg OM; Odland JØ; Sandanger TM
    Environ Int; 2014 Aug; 69():58-66. PubMed ID: 24815340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfer of perfluoroalkyl substances from mother to fetus in a Spanish birth cohort.
    Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Basterrechea M; Grimalt JO; Jiménez AM; Kraus T; Schettgen T; Sunyer J; Vrijheid M
    Environ Res; 2015 Oct; 142():471-8. PubMed ID: 26257032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal exposure to perfluoroalkyl and polyfluoroalkyl substances and the risk of hypertensive disorders of pregnancy.
    Huang R; Chen Q; Zhang L; Luo K; Chen L; Zhao S; Feng L; Zhang J
    Environ Health; 2019 Jan; 18(1):5. PubMed ID: 30626391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perfluoroalkyl Substances, Sex Hormones, and Insulin-like Growth Factor-1 at 6-9 Years of Age: A Cross-Sectional Analysis within the C8 Health Project.
    Lopez-Espinosa MJ; Mondal D; Armstrong BG; Eskenazi B; Fletcher T
    Environ Health Perspect; 2016 Aug; 124(8):1269-75. PubMed ID: 26794451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.